Skip to main content
Clinical Trials/NCT05526287
NCT05526287
Completed
Not Applicable

Effects of Dual-Task Training on Balance, Gait, Dual-Task Performance, Cognitive Function, Fatigue in People With Multiple Sclerosis

Ege University1 site in 1 country26 target enrollmentNovember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Ege University
Enrollment
26
Locations
1
Primary Endpoint
Timed Up And Go Test (TUG)
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

The purpose of this study is to investigate the effects of dual task training on balance, gait, dual-task performance, cognitive function, fatigue and functional mobility in people with Multiple Sclerosis(MS).

Detailed Description

Eligible participants will be randomized to dual-task group or control group. Dual-task group will receive 8 weeks of dual-task training twice a week and home exercise program. Control group will receive only home exercise program for 8 weeks. Each participant will be assessed before and after the 8 weeks of treatment.

Registry
clinicaltrials.gov
Start Date
November 1, 2022
End Date
August 15, 2023
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mehmet Ozkeskin

Assistant Professor

Ege University

Eligibility Criteria

Inclusion Criteria

  • Having a definitive diagnosis of MS according to the revised McDonald criteria
  • Having Expanded Disability Status Scale score between 0-5.5
  • No relapse in the last 30 days
  • Having a Mini Mental Test score of 24 and above
  • Being fluent in Turkish language
  • No condition that prevents exercising

Exclusion Criteria

  • Being pregnant
  • Presence of a neuro-musculoskeletal disease other than Multiple Sclerosis
  • Having received physiotherapy for balance and gait disorders in the last 3 months

Outcomes

Primary Outcomes

Timed Up And Go Test (TUG)

Time Frame: eight weeks

It is a frequently used test that evaluates functional mobility and dynamic balance. At the beginning of the test, individuals sit in a chair. A distance of 3 m is set in front of the patient. With the start command, the patient gets up from his seat and walks 3 m, turns around and walks back and sits. With the start command, the time until the moment of sitting on the chair is recorded in seconds.Shorter duration indicates better functional mobility.

Tetrax((Sunlight Medical Ltd, Israel),Computerized Static Posturography Device

Time Frame: eight weeks

Tetrax (Sunlight Medical Ltd, Israel) computerized posturography device consists of a platform system where data is collected, a computer and software system where data is processed and integrated. Participants will stand on the platform system in 8 different condition. Tetrax will be used to measure static balance and fall risk.

Berg Balance Scale(BBS)

Time Frame: eight weeks

BBS, evaluates daily activities including static sitting and standing balance, as well as transfers, turning, and picking up objects from the ground, in 14 items.Scoring is given as 0-4. It scores from 4 (normal performance) to 0 (not able to do the movement) according to the person's ability to do what is asked of them safely and independently. The total score is 56 points. 0-20 indicates high risk, 21-40 indicates medium risk, and 41-64 indicates low risk.

Secondary Outcomes

  • Dual-Task Questionnaire(DTQ)(eight weeks)
  • MS Walking Scale-12(MSWS-12)(eight weeks)
  • 10 Meter Walking Test(10MWT)(eight weeks)
  • Fatigue Severity Index(FSI)(eight weeks)
  • Dual-Task Performance(eight weeks)
  • Brief International Cognitive Assesment for MS(BICAMS)(eight weeks)

Study Sites (1)

Loading locations...

Similar Trials